Shenzhen New Industries Biomedical Engineering Co., Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Over the past week and month, the stock has faced notable decreases, and its one-year return is substantially negative compared to the China Shanghai Composite. Key financial metrics indicate ongoing challenges in the sector.

Shenzhen New Industries Biomedical Engineering Co., Ltd. faced a significant stock decline, reaching an intraday low and showing a notable decrease over the past week and month. The company has struggled in the long term, with a substantial drop in performance compared to the China Shanghai Composite and a challenging outlook in the pharmaceuticals sector.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a significant intraday increase on March 6, 2026, contrasting with the broader market's modest gain. Despite a recent uptick, the company has struggled over the past year, reporting a decline in profits and underperforming compared to the China Shanghai Composite.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a notable increase in its stock price today, reaching an intraday high. However, the company has struggled over the past year, with a significant decline in returns compared to the broader market. Its market capitalization is CNY 36,352 million, and it maintains a dividend yield of 2.81%.